Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor‐1α that enhances CoCl 2 ‐induced doxorubicin resistance in breast cancer cells
Author:
Affiliation:
1. School of Pharmacy Shanghai Jiao Tong University ShanghaiChina
2. Engineering Research Center of Cell and Therapeutic Antibody Ministry of Education Shanghai China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12714
Reference37 articles.
1. Global Burden of Breast Cancer
2. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years
3. Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer
4. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
5. Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Research progress in tumor angiogenesis and drug resistance in breast cancer;Cancer Biology & Medicine;2024-06-25
2. Unveiling Gene Regulatory Networks That Characterize Difference of Molecular Interplays Between Gastric Cancer Drug Sensitive and Resistance Cell Lines;Journal of Computational Biology;2024-03-01
3. Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks;Pathology - Research and Practice;2023-08
4. AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer;Frontiers in Oncology;2023-05-01
5. Interplay between LncRNAs and microRNAs in Breast Cancer;International Journal of Molecular Sciences;2023-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3